Advantage Investment Management’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
HI
FCM
Advantage Investment Management's CELG Position: Q3 2019 in Review
Advantage Investment Management reduced its Celgene Corp (CELG) stake by 64% in Q3 2019, selling an estimated $33.7K and leaving 198 shares worth $20K. The position accounts for 0.02% of the portfolio, ranked #531.
Advantage Investment Management first reported a position in CELG in Q4 2014 and has held it in 20 quarters since. The position peaked at $189K in Q4 2015. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.
- Advantage Investment Management held 198 shares of Celgene Corp worth $20K as of Q3 2019.
- Advantage Investment Management sold 355 Celgene Corp shares in Q3 2019, an estimated $33.7K.
- Celgene Corp made up 0.02% of Advantage Investment Management's portfolio in Q3 2019, its #531 holding.
- Advantage Investment Management first reported a position in Celgene Corp in Q4 2014 and has held it in 20 quarters since.
- Advantage Investment Management's Celgene Corp position peaked at $189K in Q4 2015.
- 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.
Based on Advantage Investment Management's 13F filing for Q3 2019, filed 8 Oct 2019.